User menu

Tumor-specific shared antigenic peptides recognized by human T cells

Bibliographic reference van der Bruggen, Pierre ; Zhang, Yi ; Chaux, Pascal ; Stroobant, Vincent ; Panichelli, Christophe ; et. al. Tumor-specific shared antigenic peptides recognized by human T cells. In: Immunological Reviews, Vol. 188, p. 51-64 (2002)
Permanent URL http://hdl.handle.net/2078.1/29514
  1. Boon T., Tumor Antigens Recognized by T Lymphocytes, 10.1146/annurev.immunol.12.1.337
  2. Marchand M, Exp Opin Biol Ther, 1, 497 (2001)
  3. Jäger Elke, Jäger Dirk, Knuth Alexander, Clinical cancer vaccine trials, 10.1016/s0952-7915(02)00318-7
  4. Marchand Marie, van Baren Nicolas, Weynants Patrick, Brichard Vincent, Dr�no Brigitte, Tessier Marie-H�l�ne, Rankin Elaine, Parmiani Giorgio, Arienti Flavio, Humblet Yves, Bourlond Andr�, Vanwijck Romain, Li�nard Danielle, Beauduin Marc, Dietrich Pierre-Yves, Russo Vincenzo, Kerger Joseph, Masucci Giuseppe, J�ger Elke, De Greve Jacques, Atzpodien Jens, Brasseur Francis, Coulie Pierre G., van der Bruggen Pierre, Boon Thierry, Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1, 10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.0.co;2-s
  5. Thurner Beatrice, Haendle Ina, Röder Claudia, Dieckmann Detlef, Keikavoussi Petra, Jonuleit Helmut, Bender Armin, Maczek Christian, Schreiner Doris, von den Driesch Peter, Bröcker Eva B., Steinman Ralph M., Enk Alexander, Kämpgen Eckhart, Schuler Gerold, Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma, 10.1084/jem.190.11.1669
  6. Boon T., Human tumor antigens recognized by T lymphocytes, 10.1084/jem.183.3.725
  7. HAAS GILBERT G., D'CRUZ OSMOND J., DE BAULT LAWRENCE E., Distribution of Human Leukocyte Antigen-ABC and -D/DR Antigens in the Unfixed Human Testis, 10.1111/j.1600-0897.1988.tb00234.x
  8. Põld Mehis, Zhou Jin, Chen Grace L., Hall Jeffrey M., Vescio Robert A., Berenson James R., Identification of a New, Unorthodox Member of the MAGE Gene Family, 10.1006/geno.1999.5870
  9. Lucas S, Cancer Res, 59, 4100 (1999)
  10. Chomez P, Cancer Res, 61, 5544 (2001)
  11. Boon T, Principles and practice of the biologic therapy of cancer, 493 (2000)
  12. van Baren N, Blood, 94, 1156 (1999)
  13. De Smet Charles, Courtois Stéphanie J., Faraoni Isabella, Lurquin Christophe, Szikora Jean-Pierre, De Backer Olivier, Boon Thierry, Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene, 10.1007/bf00176446
  14. De Smet C., De Backer O., Faraoni I., Lurquin C., Brasseur F., Boon T., The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation., 10.1073/pnas.93.14.7149
  15. del Mazo J, Chromosome Res, 2, 147 (1994)
  16. Herin M, Int J Cancer, 39, 390 (1987)
  17. Van den Eynde B, Int J Cancer, 44, 634 (1989)
  18. Traversari C, Immunogenetics, 35, 145 (1992)
  19. van der Bruggen P, Science, 254, 1643 (1991)
  20. Coulie P. G., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, 10.1084/jem.180.1.35
  21. Lucas Sophie, De Plaen Etienne, Boon Thierry, MAGE-B5, MAGE-B6, MAGE-C2, andMAGE-C3: four new members of theMAGE family with tumor-specific expression, 10.1002/1097-0215(20000701)87:1<55::aid-ijc8>3.0.co;2-j
  22. De Plaen E, Immunogenetics, 40, 360 (1994)
  23. Lurquin Christophe, De Smet Charles, Brasseur Francis, Muscatelli Françoise, Martelange Valérie, De Plaen Etienne, Brasseur Robert, Monaco Anthony P., Boon Thierry, Two Members of the HumanMAGEBGene Family Located in Xp21.3 Are Expressed in Tumors of Various Histological Origins, 10.1006/geno.1997.5052
  24. De Backer O, Cancer Res, 59, 3157 (1999)
  25. Muscatelli F, Proc Natl Acad Sci USA, 92, 4987 (1995)
  26. Lisitsyn N, Science, 259, 946 (1993)
  27. Hubank M, Nucl Acids Res, 22, 5640 (1994)
  28. De Smet Charles, Martelange Valérie, Lucas Sophie, Brasseur Francis, Lurquin Christophe, Boon Thierry, Identification of Human Testis-Specific Transcripts and Analysis of Their Expression in Tumor Cells, 10.1006/bbrc.1997.7868
  29. Lucas S, Cancer Res, 58, 743 (1998)
  30. Lethé Bernard, Lucas Sophie, Michaux Lucienne, De Smet Charles, Godelaine Danièle, Serrano Alfonso, De Plaen Etienne, Boon Thierry, LAGE-1, a new gene with tumor specificity, 10.1002/(sici)1097-0215(19980610)76:6<903::aid-ijc22>3.0.co;2-1
  31. Martelange V, Cancer Res, 60, 3848 (2000)
  32. Sahin Ugur, Türeci Özlem, Pfreundschuh Michael, Serological identification of human tumor antigens, 10.1016/s0952-7915(97)80053-2
  33. Grohmann U, Eur J Immunol, 25, 2797 (1995)
  34. Ossendorp Ferry, Mengedé Erica, Camps Marcel, Filius Rian, Melief Cornelis J.M., Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors, 10.1084/jem.187.5.693
  35. Natali Piergiorgio, Bigotti Aldo, Cavalieri Renato, Rita Nicotra M., Tecce Raffaele, Manfredi Dante, Chen Yu-Xien, Nadler Lee M., Ferrone Soldano, Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin, 10.1016/0198-8859(86)90028-5
  36. Taramelli D, Cancer Res, 46, 433 (1986)
  37. Pardoll Drew M, Topalian Suzanne L, The role of CD4+ T cell responses in antitumor immunity, 10.1016/s0952-7915(98)80228-8
  38. Rammensee H-G, Immunogenetics, 41, 178 (1995)
  39. Marsh SGE, The HLA Factsbook. Factsbook Series (2000)
  40. Rammensee H-G, Molecular Biology Intelligence Unit (1997)
  41. Hammer Juergen, Valsasnini Paola, Tolba Khaled, Bolin David, Higelin Jacqueline, Takacs Bela, Sinigaglia Francesco, Promiscuous and allele-specific anchors in HLA-DR-binding peptides, 10.1016/0092-8674(93)90306-b
  42. Hammer Juergen, Sturniolo Tiziana, Bono Elisa, Ding Jiayi, Raddrizzani Laura, Tuereci Oezlem, Sahin Ugur, Braxenthaler Michael, Gallazzi Fabio, Protti Maria Pia, Sinigaglia Francesco, 10.1038/9858
  43. Romani N., Proliferating dendritic cell progenitors in human blood, 10.1084/jem.180.1.83
  44. Sallusto F., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha, 10.1084/jem.179.4.1109
  45. Chaux Pascal, Vantomme Valérie, Stroobant Vincent, Thielemans Kris, Corthals Jurgen, Luiten Rosalie, Eggermont Alexander M.M., Boon Thierry, van der Bruggen Pierre, Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+T Lymphocytes, 10.1084/jem.189.5.767
  46. Sanderson S, Proc Natl Acad Sci USA, 92, 7217 (1995)
  47. van der Bruggen P, Eur J Immunol, 24, 3038 (1994)
  48. Herman Jean, van der Bruggen P., Luescher Immanuel F., Mandruzzato Susanna, Romero Pedro, Thonnard Joëlle, Fleischhauer Katharina, Boon Thierry, Coulie P. G., A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3 , 10.1007/s002510050078
  49. Skipper JCA, J Exp Med, 183, 527 (1996)
  50. Meadows Leslie, Wang Wei, den Haan Joke M.M, Blokland Els, Reinhardus Carla, Drijfhout Jan W, Shabanowitz Jeffrey, Pierce Richard, Agulnik Alexander I, Bishop Colin E, Hunt Donald F, Goulmy Els, Engelhard Victor H, The HLA-A*0201-Restricted H-Y Antigen Contains a Posttranslationally Modified Cysteine That Significantly Affects T Cell Recognition, 10.1016/s1074-7613(00)80330-1
  51. Valmori Danila, Gileadi Uzi, Servis Catherine, Dunbar P. Rod, Cerottini Jean-Charles, Romero Pedro, Cerundolo Vincenzo, Lévy Frédéric, Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3, 10.1084/jem.189.6.895
  52. Kessler Jan H., Beekman Nico J., Bres-Vloemans Sandra A., Verdijk Pauline, van Veelen Peter A., Kloosterman-Joosten Antoinette M., Vissers Debby C.J., ten Bosch George J.A., Kester Michel G.D., Sijts Alice, Drijfhout Jan Wouter, Ossendorp Ferry, Offringa Rienk, Melief Cornelis J.M., Efficient Identification of Novel Hla-A*0201–Presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen Prame by Proteasome-Mediated Digestion Analysis, 10.1084/jem.193.1.73
  53. Pascolo S, Cancer Res, 61, 4072 (2001)
  54. Barnea Eilon, Beer Ilan, Patoka Renana, Ziv Tamar, Kessler Ofra, Tzehoval Esther, Eisenbach Lea, Zavazava Nicholas, Admon Arie, Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens, 10.1002/1521-4141(200201)32:1<213::aid-immu213>3.0.co;2-8
  55. Zhong Lei, Granelli-Piperno Angela, Choi Yongwon, Steinman Ralph M., Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells, 10.1002/(sici)1521-4141(199903)29:03<964::aid-immu964>3.0.co;2-p
  56. Jonuleit H, Eur J Immunol, 27, 3135 (1997)
  57. TAYLOR J, TRIMARCHI C, WEINBERG R, LANGUET B, GUILLERMIN F, DESMETTRE P, PAOLETTI E, Efficacy studies on a canarypox-rabies recombinant virus, 10.1016/0264-410x(91)90152-v
  58. Arthur JF, Cancer Gene Ther, 4, 17 (1997)
  59. Van Tendeloo V. F. I., Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells, 10.1182/blood.v98.1.49
  60. Cornelis Guy R., Van Gijsegem Frédérique, Assembly and Function of Type III Secretory Systems, 10.1146/annurev.micro.54.1.735
  61. Boland A, Infect Immun, 66, 1878 (1998)
  62. Chaux P, J Immunol, 163, 2928 (1999)
  63. Luiten R., van der Bruggen P., A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes, 10.1034/j.1399-0039.2000.550206.x
  64. Luiten R.M., Demotte N., Tine J., van der Bruggen P., A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules, 10.1034/j.1399-0039.2000.560110.x
  65. Zemmour J, J Exp Med, 176, 937 (1992)
  66. van der Bruggen P, Eur J Immunol, 24, 2134 (1994)
  67. Traversari C, J Exp Med, 176, 1453 (1992)
  68. Boel P, Immunity, 2, 167 (1995)
  69. Van den Eynde B, J Exp Med, 182, 689 (1995)
  70. Gaugler B., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, 10.1084/jem.179.3.921
  71. Luescher Immanuel F., Romero Pedro, Kuznetsov Dmitry, Rimoldi Donata, Coulie Pierre, Cerottini Jean-Charles, Jongeneel C. Victor, HLA Photoaffinity Labeling Reveals Overlapping Binding of Homologous Melanoma-associated Gene Peptides by HLA-A1, HLA-A29, and HLA-B44, 10.1074/jbc.271.21.12463
  72. Coulie P. G., Karanikas V., Colau D., Lurquin C., Landry C., Marchand M., Dorval T., Brichard V., Boon T., A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3, 10.1073/pnas.161260098
  73. Schultz E.S., Zhang Y., Knowles R., Tine J., Traversari C., Boon T., van der Bruggen P., A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes, 10.1034/j.1399-0039.2001.057002103.x
  74. Tussey LG, Immunity, 3, 65 (1995)
  75. Wang S, J Immunol, 163, 5820 (1999)
  76. Manici Simona, Sturniolo Tiziana, Imro Maria Adele, Hammer Juergen, Sinigaglia Francesco, Noppen Christoph, Spagnoli Giulio, Mazzi Benedetta, Bellone Matteo, Dellabona Paolo, Protti Maria Pia, Melanoma Cells Present a MAGE-3 Epitope to CD4+Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11, 10.1084/jem.189.5.871
  77. Schultz ES, Cancer Res, 60, 6272 (2000)
  78. Rock Kenneth L., Goldberg Alfred L., DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDES, 10.1146/annurev.immunol.17.1.739
  79. Morel S, Immunity, 12, 107 (2000)
  80. Toes R.E.M., Nussbaum A.K., Degermann S., Schirle M., Emmerich N.P.N., Kraft M., Laplace C., Zwinderman A., Dick T.P., Müller J., Schönfisch B., Schmid C., Fehling H.-J., Stevanovic S., Rammensee H.G., Schild H., Discrete Cleavage Motifs of Constitutive and Immunoproteasomes Revealed by Quantitative Analysis of Cleavage Products, 10.1084/jem.194.1.1
  81. Driscoll James, Brown Michael G., Finley Daniel, Monaco John J., MHC-linked LMP gene products specifically alter peptidase activities of the proteasome, 10.1038/365262a0
  82. Kuckelkorn U, Eur J Immunol, 25, 2605 (1995)
  83. Van den Eynde Benoı̂t J, Morel Sandra, Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome, 10.1016/s0952-7915(00)00197-7
  84. Schultz Erwin S., Chapiro Jacques, Lurquin Christophe, Claverol Stéphane, Burlet-Schiltz Odile, Warnier Guy, Russo Vincenzo, Morel Sandra, Lévy Frédéric, Boon Thierry, Van den Eynde Benoît J., van der Bruggen Pierre, The Production of a New MAGE-3 Peptide Presented to Cytolytic T Lymphocytes by HLA-B40 Requires the Immunoproteasome, 10.1084/jem.20011974
  85. Chen J.-L., Dunbar P. R., Gileadi U., Jager E., Gnjatic S., Nagata Y., Stockert E., Panicali D. L., Chen Y.-T., Knuth A., Old L. J., Cerundolo V., Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL, 10.4049/jimmunol.165.2.948
  86. Chen Y.-T., Scanlan M. J., Sahin U., Tureci O., Gure A. O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., Old L. J., A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening, 10.1073/pnas.94.5.1914
  87. Tureci O, Cancer Res, 56, 4766 (1996)
  88. Tureci O., Sahin U., Zwick C., Koslowski M., Seitz G., Pfreundschuh M., Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens, 10.1073/pnas.95.9.5211
  89. Aarnoudse Corlien A., van den Doel Petra B., Heemskerk Bianca, Schrier Peter I., Interleukin-2-induced, melanoma-specific T cells recognize camel, an unexpected translation product ofLAGE-1, 10.1002/(sici)1097-0215(19990730)82:3<442::aid-ijc19>3.0.co;2-z
  90. Jäger Elke, Chen Yao-Tseng, Drijfhout Jan W., Karbach Julia, Ringhoffer Mark, Jäger Dirk, Arand Michael, Wada Hisashi, Noguchi Yuji, Stockert Elisabeth, Old Lloyd J., Knuth Alexander, Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes, 10.1084/jem.187.2.265
  91. Rimoldi D., Rubio-Godoy V., Dutoit V., Lienard D., Salvi S., Guillaume P., Speiser D., Stockert E., Spagnoli G., Servis C., Cerottini J.-C., Lejeune F., Romero P., Valmori D., Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma, 10.4049/jimmunol.165.12.7253
  92. Wang R-F, J Immunol, 161, 3596 (1998)
  93. Gnjatic S., Nagata Y., Jager E., Stockert E., Shankara S., Roberts B. L., Mazzara G. P., Lee S. Y., Dunbar P. R., Dupont B., Cerundolo V., Ritter G., Chen Y.-T., Knuth A., Old L. J., Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele, 10.1073/pnas.97.20.10917
  94. Jäger Elke, Jäger Dirk, Karbach Julia, Chen Yao-Tseng, Ritter Gerd, Nagata Yasuhiro, Gnjatic Sacha, Stockert Elisabeth, Arand Michael, Old Lloyd J., Knuth Alexander, Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma, 10.1084/jem.191.4.625
  95. Zeng G., Touloukian C. E., Wang X., Restifo N. P., Rosenberg S. A., Wang R.-F., Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules, 10.4049/jimmunol.165.2.1153
  96. Zarour HM, Cancer Res, 60, 4946 (2000)
  97. Fujie Tatsuo, Tahara Kouichirou, Tanaka Fumiaki, Mori Masaki, Takesako Kazutou, Akiyoshi Tsuyoshi, A MAGE‐1‐encoded HLA‐A24‐binding synthetic peptide induces specific anti‐tumor cytotoxic T lymphocytes, 10.1002/(sici)1097-0215(19990118)80:2<169::aid-ijc1>3.3.co;2-g
  98. Tanzarella S, Cancer Res, 59, 2668 (1999)
  99. Chaux Pascal, Lethé Bernard, Van Snick Jacques, Corthals Jurgen, Schultz Erwin S., Cambiaso César L., Boon Thierry, van der Bruggen Pierre, A MAGE-1 peptide recognized on HLA-DR15 by CD4+ T cells, 10.1002/1521-4141(200106)31:6<1910::aid-immu1910>3.0.co;2-k
  100. Kawashima Ichiro, Hudson Stephen J, Tsai Van, Southwood Scott, Takesako Kazutoh, Appella Ettore, Sette Alessandro, Celis Esteban, The Multi-epitope Approach for Immunotherapy for Cancer: Identification of Several CTL Epitopes from Various Tumor-Associated Antigens Expressed on Solid Epithelial Tumors, 10.1016/s0198-8859(97)00255-3
  101. Tahara K, Clin Cancer Res, 5, 2236 (1999)
  102. Tanaka F, Cancer Res, 57, 4465 (1997)
  103. Russo V., Tanzarella S., Dalerba P., Rigatti D., Rovere P., Villa A., Bordignon C., Traversari C., Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response, 10.1073/pnas.040540197
  104. Kobayashi H, Cancer Res, 61, 4773 (2001)
  105. Zorn Emmanuel, Hercend Thierry, A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion, 10.1002/(sici)1521-4141(199902)29:02<602::aid-immu602>3.0.co;2-y
  106. Huang L-Q, J Immunol, 162, 6849 (1999)
  107. Heidecker L., Brasseur F., Probst-Kepper M., Gueguen M., Boon T., Van den Eynde B. J., Cytolytic T Lymphocytes Raised Against a Human Bladder Carcinoma Recognize an Antigen Encoded by Gene MAGE-A12, 10.4049/jimmunol.164.11.6041
  108. Panelli M. C., Bettinotti M. P., Lally K., Ohnmacht G. A., Li Y., Robbins P., Riker A., Rosenberg S. A., Marincola F. M., A Tumor-Infiltrating Lymphocyte from a Melanoma Metastasis with Decreased Expression of Melanoma Differentiation Antigens Recognizes MAGE-12, 10.4049/jimmunol.164.8.4382